British regulators said they have identified 30 cases of rare blood clot events associated with the AstraZeneca vaccine but stressed the benefits of the jab in preventing coronavirus outweigh any risks.
The Medicines and Healthcare Regulatory Agency (MHRA) said on Thursday that the risk associated with this type of blood clot is “very small” and that the public should continue to take up the vaccine when offered it.
The agency said it had identified 30 cases of rare blood clot events following use of the Oxford/AstraZeneca jab, out of 18.1 million doses administered up to and including March 24.
Of these, it said it had received 22 reports of cerebral venous sinus thrombosis and eight reports of other thrombosis events with low platelets.
It comes as Covid passports are set to be trialled in the UK later this month.
New details of around a dozen pilot schemes will be announced in the coming days, the Telegraph reports.
The FA Cup final, an FA Cup semi-final, the League Cup final and the World Snooker Championship are said to be taking part, with the Brit Awards also in discussions.
